Cancer as a Metabolic Disease: What the Science Reveals About Prevention and Mitochondrial Health

A Different Way of Thinking About Cancer: Metabolism, Mitochondria, and What the Science Is Starting to Reveal

Cancer is one of the most feared diagnoses in medicine. And for good reason. Despite decades of research, enormous funding, and genuine scientific progress, cancer remains the second leading cause of death in the United States, claiming over 600,000 lives every year.

The dominant framework for understanding cancer has been the somatic mutation theory: the idea that cancer is fundamentally a genetic disease, driven by mutations in the DNA of cells that cause them to grow uncontrollably. This framework has guided cancer research and treatment for the past half-century. It has produced real advances. It has also produced a long and sobering list of failures.

I want to share a different perspective, one that is gaining traction in the research community and that has profound implications for how we think about cancer prevention. It is the view that cancer may be, at its core, a disease of mitochondrial metabolism. And if that framing is even partially correct, it changes what we might be able to do to reduce our risk.

1. The Warburg Effect: A Clue That Was Set Aside

In the 1920s, a German biochemist named Otto Warburg made an observation that was, at the time, deeply puzzling. He found that cancer cells continued to ferment sugar, producing lactic acid, even in the presence of abundant oxygen. Normal cells, when oxygen is available, use it to generate energy through a process called oxidative phosphorylation in the mitochondria. Fermentation is a far less efficient backup pathway that cells normally rely on only when oxygen is scarce.

Warburg’s observation, now called the Warburg effect, suggested something was wrong with the mitochondria of cancer cells. He proposed that the damage to cellular respiration was the primary event in cancer development, and that the abnormal fermentation was a consequence of that damage. Cancer cells, unable to generate energy efficiently through normal mitochondrial respiration, were forced to rely on fermentation of glucose as a compensatory strategy.

This idea was largely set aside after Watson and Crick’s discovery of DNA in the 1950s, as the field pivoted toward genetics and molecular biology. But the observation never went away. And a growing body of research is revisiting it with new tools and new urgency.

2. The Mitochondrial Case for Cancer

One of the most compelling pieces of evidence in this framework is the finding that in every cancer cell that has been carefully examined in its natural tissue environment, there are defects in the number, structure, and function of the mitochondria. Not in some cancers. In all of them.

A key discovery involves a molecule called cardiolipin, the signature lipid of the inner mitochondrial membrane. Cardiolipin plays a critical structural and functional role in the electron transport chain, the machinery that produces the vast majority of cellular energy through oxidative phosphorylation. In cancer cells, cardiolipin is consistently abnormal. And when cardiolipin is abnormal, the proteins of the electron transport chain cannot function properly. Energy production through normal respiration is compromised.

When cells cannot generate adequate energy through respiration, they fall back on fermentation. They begin consuming glucose and glutamine at dramatically elevated rates, using these substrates to produce energy through ancient, less efficient pathways. This is not simply a quirky metabolic signature of cancer cells. According to the metabolic theory, it is the fundamental survival strategy of a cell whose mitochondria can no longer do their primary job.

3. What Feeds a Cancer Cell

If cancer cells are dependent on fermentation, then the fuels that power fermentation, glucose and glutamine, become critically important. This is where the metabolic framework intersects with lifestyle and prevention in ways that are both sobering and actionable.

Cancer cells consume glucose at dramatically elevated rates. This is actually the basis of PET scanning in oncology: cancer cells light up on PET scans because they absorb so much radioactively labeled glucose. They also consume glutamine, an amino acid, at high rates, using it as a secondary fermentable fuel and as a building block for rapid cell division.

Normal cells, when blood glucose drops and ketones rise, can switch to using ketones as their primary fuel. Cancer cells, because of their defective mitochondria, largely cannot make this switch. They remain dependent on glucose and glutamine. This metabolic inflexibility is both a defining feature of cancer cells and, potentially, a therapeutic vulnerability.

4. The Prevention Angle: What We Can Control

This is where I want to focus, because prevention is the domain where we have the most leverage and where lifestyle choices matter most.

The metabolic theory of cancer suggests that anything that damages mitochondrial function creates an environment where cancer can develop. The list of known carcinogens, radiation, certain chemicals, chronic inflammation, viral infections, takes on new meaning through this lens. These are not primarily genetic mutagens. They are mitochondrial stressors. They damage cellular respiration. And when respiration is sufficiently impaired, fermentation begins, and the conditions for cancer emerge.

Conversely, anything that supports mitochondrial health, keeps glucose and insulin levels low, and maintains metabolic flexibility may reduce the environment in which cancer is likely to develop. The evidence for several of these interventions is compelling.

5. Hyperbaric Oxygen Therapy and the Metabolic Approach

One of the more interesting intersections between the metabolic theory of cancer and available therapies involves hyperbaric oxygen. The logic is straightforward: normal cells, which rely on oxidative phosphorylation, handle increased oxygen well and may actually benefit from it. Cancer cells, which rely on fermentation and have defective mitochondria, are more vulnerable to oxidative stress. Hyperbaric oxygen therapy may create a selective pressure that is more harmful to cancer cells than to healthy ones.

At RMRM, we offer hyperbaric oxygen therapy as part of our integrative approach to health optimization. While we are not making cancer treatment claims, the growing body of research on HBOT and its metabolic effects is a compelling area to watch.

6. An Important Note on Perspective

I want to be clear about what I am and am not saying here. The metabolic theory of cancer is a serious scientific framework supported by a meaningful body of evidence, but it is also contested and still evolving. It does not negate the role of genetics in cancer entirely. It proposes that genetic mutations in cancer may be downstream consequences of mitochondrial damage rather than the primary cause. The two frameworks are not entirely incompatible.

What the metabolic perspective offers, that the purely genetic view does not, is a set of modifiable risk factors. If cancer is, at least in part, a metabolic disease driven by mitochondrial dysfunction, then supporting mitochondrial health, maintaining metabolic flexibility, controlling blood glucose and insulin, and reducing chronic inflammation are all meaningful and actionable cancer prevention strategies.

Frequently Asked Questions By Patients

Patient Success Stories

These patient success stories reflect our commitment to treating the root biological causes of knee pain, rather than just masking symptoms. Our mission is to help you restore function, stay active, and age stronger, so you can move better and live better every day.